Lifestyle intervention to prevent diabetes

Intensive and cost effective

Judith Wylie-Rosett, William H. Herman, Ronald B. Goldberg

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Purpose of review: Type 2 diabetes is a major cause of morbidity and mortality, and despite treatment advances appears to be increasing in incidence. Since individuals at risk for the disease are usually identifiable in the prediabetic phase of impaired glucose tolerance, early intervention might prevent diabetes and hence its complications from developing. Obesity and sedentary living are powerful determinants of diabetes, and thus lifestyle change is a logical approach to prevention of this disease. Recent clinical trials have now tested the effectiveness of this intervention and form the basis for this review. Recent findings: Three clinical trials have demonstrated that, compared with usual care, lifestyle intervention significantly reduced progression rates to diabetes in prediabetic individuals. Each trial incorporated individualization and repeated long-term contacts with facilitators, in which dietary and physical activity goal setting and behavior modification were central themes. Progression to diabetes was reduced in the Da Qing study by ∼40%, in the Finnish Diabetes Prevention Study by 58% and in the Diabetes Prevention Program by 58%. The Diabetes Prevention Program included a cost-benefit unit that estimated the per capita costs of the lifestyle intervention to exceed that of the usual care group by $3540, which translated to a cost of $15 700 per case of diabetes prevented. Lifetime cost-utility analysis demonstrated an overall cost of $1100 per quality-adjusted life year. Summary: These findings make the case for translation of research findings to healthcare systems. Although there is more to be learned about effective strategies in clinical practice, it seems clear that the intervention needs to incorporate individualization and long-term interaction with trained facilitators.

Original languageEnglish (US)
Pages (from-to)37-44
Number of pages8
JournalCurrent Opinion in Lipidology
Volume17
Issue number1
StatePublished - Feb 2006

Fingerprint

Medical problems
Life Style
Costs and Cost Analysis
Cost-Benefit Analysis
Clinical Trials
Costs
Glucose Intolerance
Quality-Adjusted Life Years
Behavior Therapy
Type 2 Diabetes Mellitus
Obesity
Morbidity
Delivery of Health Care
Mortality
Incidence
Research
Glucose

Keywords

  • Clinical trials of lifestyle intervention
  • Cost-benefit analysis
  • Lifestyle change
  • Prevention of type 2 diabetes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Lifestyle intervention to prevent diabetes : Intensive and cost effective. / Wylie-Rosett, Judith; Herman, William H.; Goldberg, Ronald B.

In: Current Opinion in Lipidology, Vol. 17, No. 1, 02.2006, p. 37-44.

Research output: Contribution to journalArticle

Wylie-Rosett, Judith ; Herman, William H. ; Goldberg, Ronald B. / Lifestyle intervention to prevent diabetes : Intensive and cost effective. In: Current Opinion in Lipidology. 2006 ; Vol. 17, No. 1. pp. 37-44.
@article{79ae652e65e84f7ca800bc174c85a0dc,
title = "Lifestyle intervention to prevent diabetes: Intensive and cost effective",
abstract = "Purpose of review: Type 2 diabetes is a major cause of morbidity and mortality, and despite treatment advances appears to be increasing in incidence. Since individuals at risk for the disease are usually identifiable in the prediabetic phase of impaired glucose tolerance, early intervention might prevent diabetes and hence its complications from developing. Obesity and sedentary living are powerful determinants of diabetes, and thus lifestyle change is a logical approach to prevention of this disease. Recent clinical trials have now tested the effectiveness of this intervention and form the basis for this review. Recent findings: Three clinical trials have demonstrated that, compared with usual care, lifestyle intervention significantly reduced progression rates to diabetes in prediabetic individuals. Each trial incorporated individualization and repeated long-term contacts with facilitators, in which dietary and physical activity goal setting and behavior modification were central themes. Progression to diabetes was reduced in the Da Qing study by ∼40{\%}, in the Finnish Diabetes Prevention Study by 58{\%} and in the Diabetes Prevention Program by 58{\%}. The Diabetes Prevention Program included a cost-benefit unit that estimated the per capita costs of the lifestyle intervention to exceed that of the usual care group by $3540, which translated to a cost of $15 700 per case of diabetes prevented. Lifetime cost-utility analysis demonstrated an overall cost of $1100 per quality-adjusted life year. Summary: These findings make the case for translation of research findings to healthcare systems. Although there is more to be learned about effective strategies in clinical practice, it seems clear that the intervention needs to incorporate individualization and long-term interaction with trained facilitators.",
keywords = "Clinical trials of lifestyle intervention, Cost-benefit analysis, Lifestyle change, Prevention of type 2 diabetes",
author = "Judith Wylie-Rosett and Herman, {William H.} and Goldberg, {Ronald B.}",
year = "2006",
month = "2",
language = "English (US)",
volume = "17",
pages = "37--44",
journal = "Current Opinion in Lipidology",
issn = "0957-9672",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Lifestyle intervention to prevent diabetes

T2 - Intensive and cost effective

AU - Wylie-Rosett, Judith

AU - Herman, William H.

AU - Goldberg, Ronald B.

PY - 2006/2

Y1 - 2006/2

N2 - Purpose of review: Type 2 diabetes is a major cause of morbidity and mortality, and despite treatment advances appears to be increasing in incidence. Since individuals at risk for the disease are usually identifiable in the prediabetic phase of impaired glucose tolerance, early intervention might prevent diabetes and hence its complications from developing. Obesity and sedentary living are powerful determinants of diabetes, and thus lifestyle change is a logical approach to prevention of this disease. Recent clinical trials have now tested the effectiveness of this intervention and form the basis for this review. Recent findings: Three clinical trials have demonstrated that, compared with usual care, lifestyle intervention significantly reduced progression rates to diabetes in prediabetic individuals. Each trial incorporated individualization and repeated long-term contacts with facilitators, in which dietary and physical activity goal setting and behavior modification were central themes. Progression to diabetes was reduced in the Da Qing study by ∼40%, in the Finnish Diabetes Prevention Study by 58% and in the Diabetes Prevention Program by 58%. The Diabetes Prevention Program included a cost-benefit unit that estimated the per capita costs of the lifestyle intervention to exceed that of the usual care group by $3540, which translated to a cost of $15 700 per case of diabetes prevented. Lifetime cost-utility analysis demonstrated an overall cost of $1100 per quality-adjusted life year. Summary: These findings make the case for translation of research findings to healthcare systems. Although there is more to be learned about effective strategies in clinical practice, it seems clear that the intervention needs to incorporate individualization and long-term interaction with trained facilitators.

AB - Purpose of review: Type 2 diabetes is a major cause of morbidity and mortality, and despite treatment advances appears to be increasing in incidence. Since individuals at risk for the disease are usually identifiable in the prediabetic phase of impaired glucose tolerance, early intervention might prevent diabetes and hence its complications from developing. Obesity and sedentary living are powerful determinants of diabetes, and thus lifestyle change is a logical approach to prevention of this disease. Recent clinical trials have now tested the effectiveness of this intervention and form the basis for this review. Recent findings: Three clinical trials have demonstrated that, compared with usual care, lifestyle intervention significantly reduced progression rates to diabetes in prediabetic individuals. Each trial incorporated individualization and repeated long-term contacts with facilitators, in which dietary and physical activity goal setting and behavior modification were central themes. Progression to diabetes was reduced in the Da Qing study by ∼40%, in the Finnish Diabetes Prevention Study by 58% and in the Diabetes Prevention Program by 58%. The Diabetes Prevention Program included a cost-benefit unit that estimated the per capita costs of the lifestyle intervention to exceed that of the usual care group by $3540, which translated to a cost of $15 700 per case of diabetes prevented. Lifetime cost-utility analysis demonstrated an overall cost of $1100 per quality-adjusted life year. Summary: These findings make the case for translation of research findings to healthcare systems. Although there is more to be learned about effective strategies in clinical practice, it seems clear that the intervention needs to incorporate individualization and long-term interaction with trained facilitators.

KW - Clinical trials of lifestyle intervention

KW - Cost-benefit analysis

KW - Lifestyle change

KW - Prevention of type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=30744440867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30744440867&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 37

EP - 44

JO - Current Opinion in Lipidology

JF - Current Opinion in Lipidology

SN - 0957-9672

IS - 1

ER -